Kerr Financial Planning’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$228K Buy
908
+2
+0.2% +$430 0.25% 75
2026
Q1
$178K Buy
906
+3
+0.3% +$665 0.13% 86
2025
Q4
$197K Hold
903
0.27% 84
2025
Q3
$212K Buy
+903
New +$184K 0.3% 71

Other funds holding ABBV

Kerr Financial Planning's ABBV Position: Q2 2026 in Review

Kerr Financial Planning increased its AbbVie (ABBV) stake by 0.22% in Q2 2026, buying an estimated $430 and bringing the position to 908 shares worth $228K. The position accounts for 0.25% of the portfolio, ranked #75.

Kerr Financial Planning first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Kerr Financial Planning held 908 shares of AbbVie worth $228K as of Q2 2026.
  • Kerr Financial Planning bought 2 AbbVie shares in Q2 2026, an estimated $430.
  • AbbVie made up 0.25% of Kerr Financial Planning's portfolio in Q2 2026, its #75 holding.
  • Kerr Financial Planning first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kerr Financial Planning's 13F filing for Q2 2026, filed 2 Jul 2026.